Channing J. Paller, MD, is an Associate Professor of Oncology at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, where she specializes in the development of new prostate cancer therapeutics. She serves as director of prostate cancer clinical research at Hopkins. She earned her MD at Harvard Medical School and completed her medical residency at the Johns Hopkins Hospital, where she was a member of the Osler Housestaff Program, and her Fellowship in Medical Oncology at the Johns Hopkins Kimmel Cancer Center. She is focused on translational research and clinical trials of developmental therapeutics in prostate and other solid tumors. Her research focus is on the evaluation of new therapies, such as targeted therapies.
Research Keywords & Expertise
personalized therapy
Germline mutations
Biochemically recurren...
Novel therapeutic comb...
Fingerprints
Biochemically recurrent prostate cancer
Germline mutations
Short Biography
Channing J. Paller, MD, is an Associate Professor of Oncology at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, where she specializes in the development of new prostate cancer therapeutics. She serves as director of prostate cancer clinical research at Hopkins. She earned her MD at Harvard Medical School and completed her medical residency at the Johns Hopkins Hospital, where she was a member of the Osler Housestaff Program, and her Fellowship in Medical Oncology at the Johns Hopkins Kimmel Cancer Center. She is focused on translational research and clinical trials of developmental therapeutics in prostate and other solid tumors. Her research focus is on the evaluation of new therapies, such as targeted therapies.
